FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / News / Read News

Print

Truist Bank Agents $400MM Credit Facility for Apollo Medical Holdings

June 18, 2021, 08:00 AM

Apollo Medical Holdings completed the successful refinancing of its existing term loan and revolving credit facility with a new five-year revolving credit facility of $400.0 million, which includes a letter of credit sub-facility of up to $25.0 million and a swingline loan sub-facility of $25.0 million. Truist Bank served as administrative agent for the new facility. Truist Securities, Inc. led an arranger group that also included JPMorgan Chase Bank, MUFG Union Bank, Preferred Bank, Royal Bank of Canada and Fifth Third Bank. Wells Fargo, Bank of the West, City National Bank and TD Bank were also lenders in the transaction.

Available cash of $58.7 million and a portion of the new revolving credit facility were used to pay off the Company's existing and remaining $175.8 million term loan and $60.0 million drawn on the prior revolving credit facility maturing in September 2024. The new revolving credit facility will also be used to finance future acquisitions and investments and provide for working capital needs and other general corporate purposes. Any amounts borrowed under the revolving credit facility will bear interest at a rate of LIBOR plus 1.25%-2.5% or a base rate plus 0.25%-1.5% (determined on a quarterly basis based on the Company's leverage ratio).

Kenneth Sim, M.D., Executive Chairman and Co-Chief Executive Officer of ApolloMed, stated, "We are pleased to have completed this debt refinancing as we take proactive steps to enhance our ability to invest in growth while reducing our annual interest rate spread by 50 basis points on the initial $180.0 million drawdown and increasing our overall financial flexibility with respect to covenants and liquidity. This refinancing puts ApolloMed in a more advantageous position as we look to accelerate the growth of our business in 2021 and drive increasing value to shareholders."





Week's News



Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.